[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100461449":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":39,"responsibleParty":57,"collaborators":61,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":25,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":25,"overallStatus":41,"whyStopped":25,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Vanderbilt University Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Study Supplement","EXPERIMENTAL","Probiotic",[13],"Dietary Supplement: Probiotic",{"label":15,"type":16,"description":17,"interventionNames":18},"Study placebo","PLACEBO_COMPARATOR","Placebo",[19],"Dietary Supplement: Placebo",[21,26],{"type":22,"name":11,"description":23,"armGroupLabels":24,"otherNames":25},"DIETARY_SUPPLEMENT","Dietary supplement",[9],null,{"type":22,"name":17,"description":27,"armGroupLabels":28,"otherNames":25},"Placebo sachet",[15],[30,35],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Grace Wallace, BS","CONTACT","615-936-5356","grace.wallace@vumc.org",{"name":36,"role":32,"phone":37,"phoneExt":25,"email":38},"Emily Smith, MPH","6158757253","emily.k.smith@vumc.org",[40],{"facility":5,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"RECRUITING","Nashville","Tennessee","37232","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-86.78444,36.16589,{"lat":51,"lon":50},[54],{"name":55,"role":32,"phone":56,"phoneExt":25,"email":25},"David Crenshaw, MSW","615-322-7343",{"type":58,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Matthew S.Freiberg","Professor of Medicine",[62,64],{"name":63,"class":6},"University of Louisville",{"name":65,"class":6},"Boston University","100461449","phase-2-microbiome-metabolites-and-alcohol-in-hiv-to-reduce-cvd-rct-100461449",false,"NCT05288790","Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT","META HIV CVD","Inclusion Criteria:\n\n* HIV infected\n\nExclusion Criteria:\n\n* Not fluent in English","ALL","18 Years","89 Years",{"count":77,"type":78},250,"ESTIMATED","INTERVENTIONAL",[81],"PHASE2","Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will determine whether a pill containing healthy gut bacteria can increase the number good bacteria in the gut, lower levels of inflammation, and lower the risk of heart disease and death.",[84,85,86,87,88],"Microtia","Dysbiosis","Alcohol Drinking","HIV Infections","Cardiovascular Diseases","2025-06-18",{"date":91,"type":92},"2025-06-24","ACTUAL",{"date":94,"type":92},"2023-09-18",{"date":96,"type":78},"2027-02-28",{"name":5,"class":6},1]